Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Huang SH, Jacinto JCK, O'Sullivan B, Su J, Kim J, Ringash J, Spreafico A, Yu E, Perez-Ordonez B, Weinreb I, Cho J, Hope AJ, Bratman SV, Giuliani ME, Hosni A, Hahn E, Goldstein DP, Tong L, Eng L, Xu W, Waldron JN. Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort. Cancer. 2022 Aug 1;128(15):2908-2921. doi: 10.1002/cncr.34266. Epub 2022 May 19. PubMed PMID: 35588085.
Lassen P, Huang SH, Su J, Waldron J, Andersen M, Primdahl H, Johansen J, Kristensen CA, Andersen E, Eriksen JG, Hansen CR, Alsner J, Lilja-Fisher J, Bratman SV, Ringash J, Kim J, Hope A, Spreafico A, de Almeida J, Xu W, O'Sullivan B, Overgaard J. Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts. Int J Cancer. 2022 Apr 15;150(8):1329-1340. doi: 10.1002/ijc.33876. Epub 2021 Dec 2. PubMed PMID: 34792199.
Id Said B, Ailles L, Karamboulas C, Meens J, Huang SH, Xu W, Keshavarzi S, Bratman SV, Cho BCJ, Giuliani M, Hahn E, Kim J, O'Sullivan B, Ringash J, Waldron J, Spreafico A, de Almeida JR, Chepeha DB, Irish JC, Goldstein DP, Hope A, Hosni A. Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment. JAMA Otolaryngol Head Neck Surg. 2022 Apr 1;148(4):342-349. doi: 10.1001/jamaoto.2022.0003. PubMed PMID: 35238880; PubMed Central PMCID: PMC8895316.
Ren J, Pang W, Hueniken K, Haddad G, Hope A, Huang SH, Spreafico A, Hansen AR, Perez-Ordonez B, Goldstein DP, Bratman SV, Zhang W, Zhao Y, Xu W, de Almeida JR, Liu G. Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers. Cancer. 2022 Feb 1;128(3):497-508. doi: 10.1002/cncr.33936. Epub 2021 Oct 1. PubMed PMID: 34597435.
Sanz-Garcia E, Zhao E, Bratman SV, Siu LL. Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges. Sci Adv. 2022 Jan 28;8(4):eabi8618. doi: 10.1126/sciadv.abi8618. Epub 2022 Jan 26. Review. PubMed PMID: 35080978; PubMed Central PMCID: PMC8791609.
Chin O, Yu E, O'Sullivan B, Su J, Tellier A, Siu L, Waldron J, Kim J, Hansen A, Hope A, Cho J, Giuliani M, Ringash J, Spreafico A, Bratman S, Hosni A, Hahn E, Tong L, Xu W, Huang SH. Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort. Radiother Oncol. 2021 Dec;165:94-102. doi: 10.1016/j.radonc.2021.10.018. Epub 2021 Oct 27. PubMed PMID: 34718052.
Zazuli Z, de Jong C, Xu W, Vijverberg SJH, Masereeuw R, Patel D, Mirshams M, Khan K, Cheng D, Ordonez-Perez B, Huang S, Spreafico A, Hansen AR, Goldstein DP, de Almeida JR, Bratman SV, Hope A, Knox JJ, Wong RKS, Darling GE, Kitchlu A, van Haarlem SWA, van der Meer F, van Lindert ASR, Ten Heuvel A, Brouwer J, Ross CJD, Carleton BC, Egberts TCG, Herder GJM, Deneer VHM, Maitland-van der Zee AH, Liu G. Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study. J Pers Med. 2021 Nov 20;11(11). doi: 10.3390/jpm11111233. PubMed PMID: 34834585; PubMed Central PMCID: PMC8623115.
Leung E, Han K, Zou J, Zhao Z, Zheng Y, Wang TT, Rostami A, Siu LL, Pugh TJ, Bratman SV. HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA. Clin Cancer Res. 2021 Nov 1;27(21):5857-5868. doi: 10.1158/1078-0432.CCR-19-2384. Epub 2021 Sep 27. PubMed PMID: 34580115.
Muhanna N, Eu D, Chan HHL, Douglas C, Townson JL, Di Grappa MA, Mohamadi RM, Kelley SO, Bratman SV, Irish JC. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy. BMC Cancer. 2021 Oct 2;21(1):1075. doi: 10.1186/s12885-021-08791-8. PubMed PMID: 34600526; PubMed Central PMCID: PMC8487588.
Chiu K, Hosni A, Huang SH, Tong L, Xu W, Lu L, Bayley A, Bratman S, Cho J, Giuliani M, Kim J, Ringash J, Waldron J, Spreafico A, Irish J, Gilbert R, Gullane P, Goldstein D, O'Sullivan B, Hope A. The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity Cancer. Clin Oncol (R Coll Radiol). 2021 Oct;33(10):e442-e449. doi: 10.1016/j.clon.2021.05.007. Epub 2021 Jul 11. PubMed PMID: 34261594.
Oliva M, Chepeha D, Araujo DV, Diaz-Mejia JJ, Olson P, Prawira A, Spreafico A, Bratman SV, Shek T, de Almeida J, R Hansen A, Hope A, Goldstein D, Weinreb I, Smith S, Perez-Ordoñez B, Irish J, Torti D, Bruce JP, Wang BX, Fortuna A, Pugh TJ, Der-Torossian H, Shazer R, Attanasio N, Au Q, Tin A, Feeney J, Sethi H, Aleshin A, Chen I, Siu L. Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study. J Immunother Cancer. 2021 Oct;9(10). doi: 10.1136/jitc-2021-003476. PubMed PMID: 34599023; PubMed Central PMCID: PMC8488751.
Rostami A, Bratman SV, Han K. Liquid Biopsy Goes Viral: Next-Generation Sequencing to Enhance HPV Detection. Clin Cancer Res. 2021 Oct 1;27(19):5158-5160. doi: 10.1158/1078-0432.CCR-21-2180. PubMed PMID: 34301747.
Gudi S, O'Sullivan B, Hosni A, Su J, Hope A, Ringash J, Hueniken K, Liu G, Tong L, Goldstein D, de Almeida J, Hansen AR, Bratman SV, Cho J, Giuliani M, Hahn E, Kim J, Xu W, Waldron J, Huang SH. Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-)radiotherapy delivered under similar multidisciplinary care: A propensity-matched cohort study. Oral Oncol. 2021 Sep;120:105419. doi: 10.1016/j.oraloncology.2021.105419. Epub 2021 Jun 25. PubMed PMID: 34175612.
Cindy Yang SY, Lien SC, Wang BX, Clouthier DL, Hanna Y, Cirlan I, Zhu K, Bruce JP, El Ghamrasni S, Iafolla MAJ, Oliva M, Hansen AR, Spreafico A, Bedard PL, Lheureux S, Razak A, Speers V, Berman HK, Aleshin A, Haibe-Kains B, Brooks DG, McGaha TL, Butler MO, Bratman SV, Ohashi PS, Siu LL, Pugh TJ. Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity. Nat Commun. 2021 Aug 26;12(1):5137. doi: 10.1038/s41467-021-25432-7. PubMed PMID: 34446728; PubMed Central PMCID: PMC8390680.
Burgener JM, Zou J, Zhao Z, Zheng Y, Shen SY, Huang SH, Keshavarzi S, Xu W, Liu FF, Liu G, Waldron JN, Weinreb I, Spreafico A, Siu LL, de Almeida JR, Goldstein DP, Hoffman MM, De Carvalho DD, Bratman SV. Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2021 Aug 1;27(15):4230-4244. doi: 10.1158/1078-0432.CCR-21-0110. Epub 2021 Jun 22. PubMed PMID: 34158359.
Reiazi R, Abbas E, Famiyeh P, Rezaie A, Kwan JYY, Patel T, Bratman SV, Tadic T, Liu FF, Haibe-Kains B. The impact of the variation of imaging parameters on the robustness of Computed Tomography radiomic features: A review. Comput Biol Med. 2021 Jun;133:104400. doi: 10.1016/j.compbiomed.2021.104400. Epub 2021 Apr 16. Review. PubMed PMID: 33930766.
Reiazi R, Arrowsmith C, Welch M, Abbas-Aghababazadeh F, Eeles C, Tadic T, Hope AJ, Bratman SV, Haibe-Kains B. Prediction of Human Papillomavirus (HPV) Association of Oropharyngeal Cancer (OPC) Using Radiomics: The Impact of the Variation of CT Scanner. Cancers (Basel). 2021 May 8;13(9). doi: 10.3390/cancers13092269. PubMed PMID: 34066857; PubMed Central PMCID: PMC8125906.
Arrowsmith C, Reiazi R, Welch ML, Kazmierski M, Patel T, Rezaie A, Tadic T, Bratman S, Haibe-Kains B. Automated detection of dental artifacts for large-scale radiomic analysis in radiation oncology. Phys Imaging Radiat Oncol. 2021 Apr;18:41-47. doi: 10.1016/j.phro.2021.04.001. eCollection 2021 Apr. PubMed PMID: 34258406; PubMed Central PMCID: PMC8254196.
Sananmuang T, Yu E, Su J, O'Sullivan B, Rathod S, Chan B, Bartlett E, Waldron J, Ringash J, Kim J, Bratman SV, Hope A, Spreafico A, Hansen AR, de Almeida J, Goldstein DP, Witterick I, Tong L, Xu W, Huang SH. Pre- and Post-Radiotherapy Radiologic Nodal Features and Oropharyngeal Cancer Outcomes. Laryngoscope. 2021 Apr;131(4):E1162-E1171. doi: 10.1002/lary.29045. Epub 2020 Oct 1. PubMed PMID: 33002201.
Oliva M, Schneeberger PHH, Rey V, Cho M, Taylor R, Hansen AR, Taylor K, Hosni A, Bayley A, Hope AJ, Bratman SV, Ringash J, Singh S, Weinreb I, Perez-Ordoñez B, Chepeha D, Waldron J, Xu W, Guttman D, Siu LL, Coburn B, Spreafico A. Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study). Br J Cancer. 2021 Apr;124(9):1543-1551. doi: 10.1038/s41416-020-01253-1. Epub 2021 Mar 10. PubMed PMID: 33750907; PubMed Central PMCID: PMC8076306.
Wong ET, Huang SH, O'Sullivan B, Persaud V, Su J, Waldron J, Goldstein DP, de Almeida J, Ringash J, Kim J, Hope A, Bratman S, Cho J, Giuliani M, Hosni A, Spreafico A, Hansen A, Tong L, Xu W, Yu E. Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy. Radiother Oncol. 2021 Apr;157:255-262. doi: 10.1016/j.radonc.2021.02.005. Epub 2021 Feb 16. PubMed PMID: 33600871.
de Almeida JR, Seungyeon Kim V, O'Sullivan B, Goldstein DP, Bratman SV, Hui Huang S, Su J, Xu W, Parulekar W, Waldron JN, Hosni A. Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern survey. Oral Oncol. 2021 Mar;114:105165. doi: 10.1016/j.oraloncology.2020.105165. Epub 2021 Jan 30. PubMed PMID: 33524796.
Pilar A, Yu E, Su J, O'Sullivan B, Bartlett E, Waldron JN, Ringash J, Spreafico A, Hansen AR, de Almeida J, Bayley A, Bratman SV, Cho J, Giuliani M, Hope A, Hosni A, Kim J, Tong L, Xu W, Huang SH. Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinoma. Oral Oncol. 2021 Mar;114:105167. doi: 10.1016/j.oraloncology.2020.105167. Epub 2021 Jan 25. PubMed PMID: 33508706.
Huang SH, de Almeida JR, Watson E, Glogauer M, Xu W, Keshavarzi S, O'Sullivan B, Ringash J, Hope A, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, Waldron J, Spreafico A, Goldstein DP, Chepeha DB, Li T, Hosni A. Short-term and long-term unstimulated saliva flow following unilateral vs bilateral radiotherapy for oropharyngeal carcinoma. Head Neck. 2021 Feb;43(2):456-466. doi: 10.1002/hed.26496. Epub 2020 Oct 15. Review. PubMed PMID: 33058305.
Hosni A, Chiu K, Huang SH, Xu W, Huang J, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, O'Sullivan B, Ringash J, Waldron J, Spreafico A, de Almeida JR, Monteiro E, Witterick I, Chepeha DB, Gilbert RW, Irish JC, Goldstein DP, Hope A. Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach. Radiother Oncol. 2021 Jan;154:70-75. doi: 10.1016/j.radonc.2020.08.013. Epub 2020 Aug 28. PubMed PMID: 32861702; PubMed Central PMCID: PMC7453211.
Sanduleanu S, Jochems A, Upadhaya T, Even AJG, Leijenaar RTH, Dankers FJWM, Klaassen R, Woodruff HC, Hatt M, Kaanders HJAM, Hamming-Vrieze O, van Laarhoven HWM, Subramiam RM, Huang SH, O'Sullivan B, Bratman SV, Dubois LJ, Miclea RL, Di Perri D, Geets X, Crispin-Ortuzar M, Apte A, Deasy JO, Oh JH, Lee NY, Humm JL, Schöder H, De Ruysscher D, Hoebers F, Lambin P. Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures. Radiother Oncol. 2020 Dec;153:97-105. doi: 10.1016/j.radonc.2020.10.016. Epub 2020 Nov 1. PubMed PMID: 33137396.
Zhao EY, Bratman SV. Emerging Precision Oncology Applications of Liquid Biopsy using Circulating Tumour DNA and Methylome Profiling. Clin Oncol (R Coll Radiol). 2020 Oct;32(10):626-631. doi: 10.1016/j.clon.2020.05.022. Epub 2020 Jun 23. PubMed PMID: 32586654.
Shi W, Misra S, Li M, Su J, Chong LP, McCuske M, Williams J, Xu W, Ghoraie LS, Sutherland DR, Han K, Minden MD, Bratman SV, Yip KW, Liu FF. Inflammatory Biomarkers, Hematopoietic Stem Cells, and Symptoms in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy. JNCI Cancer Spectr. 2020 Oct;4(5):pkaa037. doi: 10.1093/jncics/pkaa037. eCollection 2020 Oct. PubMed PMID: 33134822; PubMed Central PMCID: PMC7583146.
Schmid S, Stewart EL, Martins-Filho SN, Cabanero M, Wang A, Bao H, Wu X, Patel D, Chen Z, Law JH, Bradbury PA, Shepherd FA, Leighl N, Tsao MS, Pugh T, Bratman SV, Sacher A, Liu G. Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib. Clin Lung Cancer. 2020 Sep;21(5):e488-e492. doi: 10.1016/j.cllc.2020.03.009. Epub 2020 Apr 9. PubMed PMID: 32389504.
Day D, Prawira A, Spreafico A, Waldron J, Karithanam R, Giuliani M, Weinreb I, Kim J, Cho J, Hope A, Bayley A, Ringash J, Bratman SV, Jang R, O'Sullivan B, Siu LL, Hansen AR. Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck. Oral Oncol. 2020 Sep;108:104753. doi: 10.1016/j.oraloncology.2020.104753. Epub 2020 May 25. PubMed PMID: 32464516.
De Michino S, Aparnathi M, Rostami A, Lok BH, Bratman SV. The Utility of Liquid Biopsies in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2020 Aug 1;107(5):873-886. doi: 10.1016/j.ijrobp.2020.05.008. Epub 2020 May 14. Review. PubMed PMID: 32417410.
Huang SH, O'Sullivan B, Su J, Ringash J, Bratman SV, Kim J, Hosni A, Bayley A, Cho J, Giuliani M, Hope A, Spreafico A, Hansen AR, Siu LL, Gilbert R, Irish JC, Goldstein D, de Almeida J, Tong L, Xu W, Waldron J. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal. Cancer. 2020 Aug 1;126(15):3426-3437. doi: 10.1002/cncr.32968. Epub 2020 Jun 1. PubMed PMID: 32478895; PubMed Central PMCID: PMC7300809.
Malkin EZ, Bratman SV. Bioactive DNA from extracellular vesicles and particles. Cell Death Dis. 2020 Jul 27;11(7):584. doi: 10.1038/s41419-020-02803-4. Review. PubMed PMID: 32719324; PubMed Central PMCID: PMC7385258.
McDowell L, So N, Keshavarzi S, Xu W, Rock K, Chan B, Waldron J, Bernstein LJ, Hui Huang S, Giuliani M, Hope A, O'Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Ringash J. Sexual satisfaction in nasopharyngeal carcinoma survivors: Rates and determinants. Oral Oncol. 2020 Jul 14;109:104865. doi: 10.1016/j.oraloncology.2020.104865. [Epub ahead of print] PubMed PMID: 32679542.
Rostami A, Lambie M, Yu CW, Stambolic V, Waldron JN, Bratman SV. Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics. Cell Rep. 2020 Jun 30;31(13):107830. doi: 10.1016/j.celrep.2020.107830. PubMed PMID: 32610131.
Oliva M, Huang SH, Taylor R, Su J, Xu W, Hansen AR, Jang R, Bayley A, Hosni A, Giuliani M, Ringash J, Bratman SV, Cho J, Irish J, Waldron J, Weinreb I, Kim J, O'Sullivan B, Siu LL, Spreafico A. Impact of cumulative cisplatin dose and adjuvant chemotherapy in locally-advanced nasopharyngeal carcinoma treated with definitive chemoradiotherapy. Oral Oncol. 2020 Jun;105:104666. doi: 10.1016/j.oraloncology.2020.104666. Epub 2020 Apr 6. PubMed PMID: 32272384.
Ren J, Xu W, Su J, Ren X, Cheng D, Chen Z, Bender N, Mirshams M, Habbous S, de Almeida JR, Perez-Ordonez B, Goldstein DP, Wang JR, Bratman SV, Huang SH, Jang R, Zhao Y, Waterboer T, Hung RJ, Liu G. Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable. Int J Cancer. 2020 Apr 15;146(8):2166-2174. doi: 10.1002/ijc.32548. Epub 2019 Jul 23. PubMed PMID: 31269236.
Huang SH, O'Sullivan B, Su J, Bartlett E, Kim J, Waldron JN, Ringash J, de Almeida JR, Bratman S, Hansen A, Bayley A, Cho J, Giuliani M, Hope A, Hosni A, Spreafico A, Siu L, Chepeha D, Tong L, Xu W, Yu E. Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification. Radiother Oncol. 2020 Mar;144:13-22. doi: 10.1016/j.radonc.2019.10.011. Epub 2019 Nov 8. PubMed PMID: 31710939.
Lukovic J, Alfaraj FA, Mierzwa ML, Marta GN, Xu W, Su J, Moraes FY, Huang SH, Bratman SV, O'Sullivan B, Kim JJ, Ringash JG, Waldron J, de Almeida JR, Goldstein DP, Casper KA, Rosko AJ, Spector ME, Kowalski LP, Hope A, Hosni A. Development and validation of a clinical prediction-score model for distant metastases in major salivary gland carcinoma. Ann Oncol. 2020 Feb;31(2):295-301. doi: 10.1016/j.annonc.2019.10.024. Epub 2019 Dec 16. PubMed PMID: 31959347.
So N, McDowell LJ, Lu L, Xu W, Rock K, Waldron J, Bernstein LJ, Chan HB, Huang SH, Giuliani M, Hope A, O'Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Ringash J. The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):134-145. doi: 10.1016/j.ijrobp.2019.09.008. Epub 2019 Sep 27. PubMed PMID: 31568813.
de Almeida JR, Noel CW, Veigas M, Martino R, Chepeha DB, Bratman SV, Goldstein DP, Hansen AR, Yu E, Metser U, Weinreb I, Perez-Ordonez B, Xu W, Kim J. Finding/identifying primaries with neck disease (FIND) clinical trial protocol: a study integrating transoral robotic surgery, histopathological localisation and tailored deintensification of radiotherapy for unknown primary and small oropharyngeal head and neck squamous cell carcinoma. BMJ Open. 2019 Dec 30;9(12):e035431. doi: 10.1136/bmjopen-2019-035431. PubMed PMID: 31892671; PubMed Central PMCID: PMC6955504.
Manem VS, Lambie M, Smith I, Smirnov P, Kofia V, Freeman M, Koritzinsky M, Abazeed ME, Haibe-Kains B, Bratman SV. Modeling Cellular Response in Large-Scale Radiogenomic Databases to Advance Precision Radiotherapy. Cancer Res. 2019 Dec 15;79(24):6227-6237. doi: 10.1158/0008-5472.CAN-19-0179. Epub 2019 Sep 26. PubMed PMID: 31558563; PubMed Central PMCID: PMC8128135.
Esfahani MS, Lee LJ, Jeon YJ, Flynn RA, Stehr H, Hui AB, Ishisoko N, Kildebeck E, Newman AM, Bratman SV, Porteus MH, Chang HY, Alizadeh AA, Diehn M. Functional significance of U2AF1 S34F mutations in lung adenocarcinomas. Nat Commun. 2019 Dec 13;10(1):5712. doi: 10.1038/s41467-019-13392-y. PubMed PMID: 31836708; PubMed Central PMCID: PMC6911043.
Dowling RJO, Sparano JA, Goodwin PJ, Bidard FC, Cescon DW, Chandarlapaty S, Deasy JO, Dowsett M, Gray RJ, Henry NL, Meric-Bernstam F, Perlmutter J, Sledge GW, Thorat MA, Bratman SV, Carey LA, Chang MC, DeMichele A, Ennis M, Jerzak KJ, Korde LA, Lohmann AE, Mamounas EP, Parulekar WR, Regan MM, Schramek D, Stambolic V, Whelan TJ, Wolff AC, Woodgett JR, Kalinsky K, Hayes DF. Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions. JNCI Cancer Spectr. 2019 Dec;3(4):pkz049. doi: 10.1093/jncics/pkz049. eCollection 2019 Dec. PubMed PMID: 32337478; PubMed Central PMCID: PMC7050024.
Dowling RJO, Kalinsky K, Hayes DF, Bidard FC, Cescon DW, Chandarlapaty S, Deasy JO, Dowsett M, Gray RJ, Henry NL, Meric-Bernstam F, Perlmutter J, Sledge GW, Bratman SV, Carey LA, Chang MC, DeMichele A, Ennis M, Jerzak KJ, Korde LA, Lohmann AE, Mamounas EP, Parulekar WR, Regan MM, Schramek D, Stambolic V, Thorat MA, Whelan TJ, Wolff AC, Woodgett JR, Sparano JA, Goodwin PJ. Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations. JNCI Cancer Spectr. 2019 Dec;3(4):pkz050. doi: 10.1093/jncics/pkz050. eCollection 2019 Dec. PubMed PMID: 32337479; PubMed Central PMCID: PMC7049988.
Shen SY, Burgener JM, Bratman SV, De Carvalho DD. Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA. Nat Protoc. 2019 Oct;14(10):2749-2780. doi: 10.1038/s41596-019-0202-2. Epub 2019 Aug 30. PubMed PMID: 31471598.
de Almeida JR, Yao CMKL, Ziai H, Staibano P, Huang SH, Hosni A, Hope A, Bratman SV, Monteiro E, Gilbert RW, Brown DH, Gullane PJ, Irish JC, Su J, Xu W, Goldstein DP. Postoperative wound infections, neutrophil-to-lymphocyte ratio, and cancer recurrence in patients with oral cavity cancer undergoing surgical resection. Oral Oncol. 2019 Oct;97:23-30. doi: 10.1016/j.oraloncology.2019.07.023. Epub 2019 Aug 7. PubMed PMID: 31421467.
Alfaraj F, Craig T, Huang SH, O'Sullivan B, Su J, Bayley A, Bratman S, Cho J, Giuliani M, Kim J, Ringash J, Waldron J, Hansen A, de Almeida J, Perez-Ordonez B, Weinreb I, Tong L, Xu W, Hope A. Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapy. Oral Oncol. 2019 Oct;97:124-130. doi: 10.1016/j.oraloncology.2019.05.012. Epub 2019 Sep 11. PubMed PMID: 31521053.
Ren J, Yang W, Su J, Ren X, Fazelzad R, Albert T, Habbous S, Goldstein DP, de Almeida JR, Hansen A, Jang R, Bratman SV, Hope A, Chen R, Wang J, Xu Y, Cheng D, Zhao Y, Xu W, Liu G. Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region. Int J Cancer. 2019 Sep 15;145(6):1465-1474. doi: 10.1002/ijc.32164. Epub 2019 Feb 19. PubMed PMID: 30698281.
Philp L, Chan H, Rouzbahman M, Rostami A, Ding L, Bratman SV, Akens MK, Irish JC, Bernardini MQ, Zheng G. An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells. J Vis Exp. 2019 Sep 12;(151). doi: 10.3791/59340. PubMed PMID: 31566617.
What would you like to do?